The University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. MD Anderson is one of only 41 comprehensive cancer centers designated by the National Cancer Institute (NCI). For ten of the past 12 years, including 2013, MD Anderson has ranked No. 1 in cancer care in “Best Hospitals,” a survey published annually in U.S. News & World Report. MD Anderson receives a cancer center support grant from the NCI of the National Institutes of Health.

Contact information:

Houston , TX

Programs

The Benefits of Exercise During CLL Treatment

What are the benefits of exercise for CLL patients—even during treatment? Watch as an expert panel explains the positive effects of exercise on the mind and body.

Published:

Understanding Chromosomal Abnormalities in CLL Patients

What are high-risk CLL chromosomal abnormalities, and how could they impact treatment? Listen as Drs. Susan Leclair and William Wierda explain.

Published:

How Are Lab Test Reference Ranges Determined?

What do lab test reference ranges mean, and how are they established? Drs. Susan Leclair and William Wierda explain.

Published:

Why Are My Neutrophils and Platelets Monitored So Closely?

Why are your neutrophils and platelets are monitored so closely? Learn more from Dr. William Wierda and Dr. Susan Leclair.

Published:

Michele Nadeem-Baker Video Blog: Month 6

An insider’s view into her FCR/ibrutinib clinical trial at Dana-Farber Cancer Institute. With Michele Nadeem-Baker and Jeffrey Hellman, PA-C.

Published:

CAR T-Cell Therapy: An Overview

What is a CAR and what role does CAR T-cell therapy play in targeted therapy? Experts Drs. Nicole Lamanna and Michael Keating explain.

Published:

What Is a CBC Test and Why Did Your Doctor Order It?

Learn more about CBCs, including what your doctor is looking for and how the information is gathered in the lab. With Drs. William Wierda and Susan Leclair.

Published:

Checkpoint Inhibitors and CLL: An Update

Learn more about harnessing the immune system for CLL and Richter’s transformation with Drs. Nicole Lamanna and Michael Keating.

Published:

Webinar Replay: Understanding and Interpreting Complete Blood Count (CBC) Results

Watch the replay of our virtual webinar, as Patient Power founder Andrew Schorr leads a panel of experts, including Dr. William Wierda, Dr. Susan Leclair and Lynn Ingram, in a discussion on the meanings of lab test results in easy-to-understand terms.

Published:

Showing 9 of 258 programs

Page last updated on February 19, 2015